av/merrimack-pharmaceuticals--big.svg

NASDAQ:MACK

Merrimack Pharmaceuticals, Inc.

  • Stock

USD

Last Close

15.13

17/05 19:59

Market Cap

223.97M

Beta: 1.80

Volume Today

922.50K

Avg: 70.31K

PE Ratio

−152.04

PFCF: −135.35

OverviewFinancialsAPI

    Description

    Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -2.5-2-1.5-1-0.52017-03-012019-03-062020-08-072022-08-042024-05-02

    Revenue (Estimate*)

    50M100M150M200M2017-03-012019-03-062020-08-072022-08-042024-05-02

    *Estimate based on analyst consensus